HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China · Delayed Price · Currency is CNY 10.18
+0.40 (4.09%)
Nov 13, 2026, 3:00 PM CST
SHA:600829 Market Cap
SHA:600829 has a market cap or net worth of 5.9 billion as of November 13, 2026. It is the 10,779th most valuable company in the world and the 2,529th biggest in China. Its market cap has decreased by 18.56% in one year.
Market Cap
5.90B
Enterprise Value
5.94B
Revenue
10.64B
Global Rank
Country Rank
#2,529 China
PE Ratio
37.22
ChartMarket Cap Chart
Since May 17, 2006, SHA:600829's market cap has increased from 3.63B to 5.90B, an increase of 62.79%. That is a compound annual growth rate of 2.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 5.90B | -5.83% |
| Dec 31, 2025 | 6.27B | 44.13% |
| Dec 31, 2024 | 4.35B | -4.09% |
| Dec 29, 2023 | 4.53B | 22.57% |
| Dec 30, 2022 | 3.70B | -5.06% |
| Dec 31, 2021 | 3.90B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dezhan Healthcare Company | 6.04B |
| Hunan Er-Kang Pharmaceutical | 6.02B |
| Beijing Sun-Novo Pharmaceutical Research | 5.99B |
| Guizhou Bailing Group Pharmaceutical | 5.97B |
| Suzhou Highfine Biotech | 5.91B |
| Cisen Pharmaceutical | 5.88B |
| Jinghua Pharmaceutical Group | 5.80B |
| Bide Pharmatech | 5.79B |